| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sulfotransferase activity | 4.28e-05 | 55 | 141 | 5 | GO:0008146 | |
| GeneOntologyMolecularFunction | linoleate 9S-lipoxygenase activity | 4.95e-05 | 2 | 141 | 2 | GO:1990136 | |
| GeneOntologyMolecularFunction | protein-tyrosine sulfotransferase activity | 4.95e-05 | 2 | 141 | 2 | GO:0008476 | |
| GeneOntologyMolecularFunction | arachidonate 8(R)-lipoxygenase activity | 4.95e-05 | 2 | 141 | 2 | GO:0047677 | |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 1.48e-04 | 3 | 141 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 1.48e-04 | 3 | 141 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.48e-04 | 3 | 141 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.78e-04 | 74 | 141 | 5 | GO:0016782 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.92e-04 | 118 | 141 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.33e-04 | 230 | 141 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 4.88e-04 | 5 | 141 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.92e-04 | 28 | 141 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 1.22e-03 | 30 | 141 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 1.22e-03 | 30 | 141 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 1.34e-03 | 31 | 141 | 3 | GO:0022839 | |
| GeneOntologyCellularComponent | myosin II filament | 1.31e-04 | 3 | 139 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | CKM complex | 4.33e-04 | 5 | 139 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | focal adhesion | MYH9 ASAP3 NFASC CORO1B ITGA1 ACTR3 FOCAD DCTN4 RPL13A ALOX15B | 6.27e-04 | 431 | 139 | 10 | GO:0005925 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 6.47e-04 | 6 | 139 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | mitochondrial matrix | HSPE1 AMT ETFA POLRMT TERT DECR1 PTCD1 DGUOK MCAT TRMT61B TRMT5 | 7.59e-04 | 523 | 139 | 11 | GO:0005759 |
| GeneOntologyCellularComponent | cell-substrate junction | MYH9 ASAP3 NFASC CORO1B ITGA1 ACTR3 FOCAD DCTN4 RPL13A ALOX15B | 7.74e-04 | 443 | 139 | 10 | GO:0030055 |
| Domain | P-loop_NTPase | WSCD1 TPST2 TPST1 DNAH3 MYH9 KIF16B ABCC5 RRAD HNRNPUL1 DNAH1 ARL6 MYH14 MPP4 DGUOK HS2ST1 EIF4A2 MFN2 CARD11 MYO15A CHST3 | 6.60e-06 | 848 | 142 | 20 | IPR027417 |
| Domain | - | WSCD1 TPST2 TPST1 DNAH3 ABCC5 RRAD HNRNPUL1 DNAH1 ARL6 MPP4 DGUOK HS2ST1 EIF4A2 MFN2 CARD11 MYO15A CHST3 | 5.29e-05 | 746 | 142 | 17 | 3.40.50.300 |
| Domain | TPST | 5.74e-05 | 2 | 142 | 2 | IPR026634 | |
| Domain | Sulfotransfer_1 | 1.56e-04 | 36 | 142 | 4 | PF00685 | |
| Domain | Sulfotransferase_dom | 1.56e-04 | 36 | 142 | 4 | IPR000863 | |
| Domain | Arp3_met | 1.71e-04 | 3 | 142 | 2 | IPR015623 | |
| Domain | HnRNPA1 | 1.71e-04 | 3 | 142 | 2 | IPR021662 | |
| Domain | HnRNPA1 | 1.71e-04 | 3 | 142 | 2 | PF11627 | |
| Domain | IQ | 3.81e-04 | 81 | 142 | 5 | SM00015 | |
| Domain | TPR-like_helical_dom | 4.16e-04 | 233 | 142 | 8 | IPR011990 | |
| Domain | IQ_motif_EF-hand-BS | 6.20e-04 | 90 | 142 | 5 | IPR000048 | |
| Domain | IQ | 7.19e-04 | 93 | 142 | 5 | PS50096 | |
| Domain | TRP_2 | 8.44e-04 | 6 | 142 | 2 | PF08344 | |
| Domain | LipOase_mml | 8.44e-04 | 6 | 142 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 8.44e-04 | 6 | 142 | 2 | PS00711 | |
| Domain | LipOase_C | 8.44e-04 | 6 | 142 | 2 | IPR013819 | |
| Domain | LIPOXYGENASE_2 | 8.44e-04 | 6 | 142 | 2 | PS00081 | |
| Domain | LipOase_Fe_BS | 8.44e-04 | 6 | 142 | 2 | IPR020833 | |
| Domain | LipOase_CS | 8.44e-04 | 6 | 142 | 2 | IPR020834 | |
| Domain | TRP_dom | 8.44e-04 | 6 | 142 | 2 | IPR013555 | |
| Domain | Lipoxygenase | 8.44e-04 | 6 | 142 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 8.44e-04 | 6 | 142 | 2 | PS51393 | |
| Domain | LipOase | 8.44e-04 | 6 | 142 | 2 | IPR000907 | |
| Domain | - | 1.05e-03 | 207 | 142 | 7 | 1.25.40.10 | |
| Domain | TRPC_channel | 1.18e-03 | 7 | 142 | 2 | IPR002153 | |
| Domain | Ank | 1.82e-03 | 228 | 142 | 7 | PF00023 | |
| Domain | RRM | 1.91e-03 | 230 | 142 | 7 | PS50102 | |
| Domain | - | 2.66e-03 | 244 | 142 | 7 | 3.30.70.330 | |
| Domain | Myosin_head_motor_dom | 2.99e-03 | 38 | 142 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.99e-03 | 38 | 142 | 3 | PS51456 | |
| Domain | Myosin_head | 2.99e-03 | 38 | 142 | 3 | PF00063 | |
| Domain | MYSc | 2.99e-03 | 38 | 142 | 3 | SM00242 | |
| Domain | TRP_channel | 3.02e-03 | 11 | 142 | 2 | IPR004729 | |
| Domain | Spy1 | 3.02e-03 | 11 | 142 | 2 | PF11357 | |
| Domain | Speedy | 3.02e-03 | 11 | 142 | 2 | IPR020984 | |
| Domain | ANK | 3.12e-03 | 251 | 142 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 3.25e-03 | 253 | 142 | 7 | PS50088 | |
| Domain | ANK_REP_REGION | 3.33e-03 | 254 | 142 | 7 | PS50297 | |
| Domain | Nucleotide-bd_a/b_plait | 3.62e-03 | 258 | 142 | 7 | IPR012677 | |
| Domain | Ankyrin_rpt | 3.94e-03 | 262 | 142 | 7 | IPR002110 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.92e-03 | 14 | 142 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.92e-03 | 14 | 142 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.92e-03 | 14 | 142 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.92e-03 | 14 | 142 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.92e-03 | 14 | 142 | 2 | IPR011704 | |
| Domain | MT | 4.92e-03 | 14 | 142 | 2 | PF12777 | |
| Domain | AAA_8 | 4.92e-03 | 14 | 142 | 2 | PF12780 | |
| Domain | AAA_5 | 4.92e-03 | 14 | 142 | 2 | PF07728 | |
| Domain | RRM_1 | 5.19e-03 | 208 | 142 | 6 | PF00076 | |
| Domain | DHC_fam | 5.65e-03 | 15 | 142 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.65e-03 | 15 | 142 | 2 | PF03028 | |
| Domain | Myosin_N | 5.65e-03 | 15 | 142 | 2 | PF02736 | |
| Domain | Dynein_heavy_dom | 5.65e-03 | 15 | 142 | 2 | IPR004273 | |
| Domain | Myosin_N | 5.65e-03 | 15 | 142 | 2 | IPR004009 | |
| Domain | TPR-contain_dom | 5.81e-03 | 150 | 142 | 5 | IPR013026 | |
| Domain | Ank_2 | 6.08e-03 | 215 | 142 | 6 | PF12796 | |
| Domain | RRM | 6.35e-03 | 217 | 142 | 6 | SM00360 | |
| Domain | TF_T-box | 7.24e-03 | 17 | 142 | 2 | IPR001699 | |
| Domain | TBOX | 7.24e-03 | 17 | 142 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 7.24e-03 | 17 | 142 | 2 | IPR018186 | |
| Domain | - | 7.24e-03 | 17 | 142 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 7.24e-03 | 17 | 142 | 2 | PS50252 | |
| Domain | T-box | 7.24e-03 | 17 | 142 | 2 | PF00907 | |
| Domain | TBOX_1 | 7.24e-03 | 17 | 142 | 2 | PS01283 | |
| Domain | TBOX_2 | 7.24e-03 | 17 | 142 | 2 | PS01264 | |
| Pubmed | RPL29 MYH9 HNRNPA3 HNRNPA1L2 HNRNPA1 ACTR3 DECR1 MYH14 RPL13A | 9.18e-07 | 245 | 144 | 9 | 21182205 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 22896637 | ||
| Pubmed | 3.27e-06 | 286 | 144 | 9 | 32041737 | ||
| Pubmed | HSPE1 RPL29 MYH9 CALHM1 SENP3 TNRC6B ABCC5 HNRNPUL1 HNRNPA1 CDCA2 ARL6 THADA CCDC88A EEF2K | 4.66e-06 | 777 | 144 | 14 | 35844135 | |
| Pubmed | ASNSD1 HSPE1 ASXL1 SOX17 TNRC6B XRCC1 HNRNPUL1 RFX7 ACTR3 CIC PRDM2 CDCA2 ZNF462 MYH14 TTC31 NFKB1 TBR1 HERC1 RPL13A | 7.48e-06 | 1429 | 144 | 19 | 35140242 | |
| Pubmed | RPL29 PATZ1 SENP3 HNRNPA3 POLRMT CORO1B MSI1 CCDC88A RPL13A MAN1B1 | 1.02e-05 | 417 | 144 | 10 | 36537216 | |
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 37572655 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL29 MYH9 HNRNPA3 POLRMT CORO1B XRCC1 HNRNPUL1 HNRNPA1 ACTR3 MYH14 DCTN4 RPL13A | 1.25e-05 | 626 | 144 | 12 | 33644029 |
| Pubmed | K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation. | 1.49e-05 | 12 | 144 | 3 | 26390156 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 32960212 | ||
| Pubmed | Neurofascins are required to establish axonal domains for saltatory conduction. | 1.70e-05 | 2 | 144 | 2 | 16337912 | |
| Pubmed | siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. | 1.70e-05 | 2 | 144 | 2 | 15215364 | |
| Pubmed | Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function. | 1.70e-05 | 2 | 144 | 2 | 38334757 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 1.70e-05 | 2 | 144 | 2 | 30585107 | |
| Pubmed | MAGUK-controlled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity. | 1.70e-05 | 2 | 144 | 2 | 20008554 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16129665 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 24376652 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31044597 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 25312244 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28912364 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 17046811 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23892592 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23951251 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 32560467 | ||
| Pubmed | Shear stress mediates tyrosylprotein sulfotransferase isoform shift in human endothelial cells. | 1.70e-05 | 2 | 144 | 2 | 12056800 | |
| Pubmed | CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. | 1.70e-05 | 2 | 144 | 2 | 12356734 | |
| Pubmed | Mass spectrometric kinetic analysis of human tyrosylprotein sulfotransferase-1 and -2. | 1.70e-05 | 2 | 144 | 2 | 18672380 | |
| Pubmed | Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo. | 1.70e-05 | 2 | 144 | 2 | 19047058 | |
| Pubmed | Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1. | 1.70e-05 | 2 | 144 | 2 | 11774503 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 11774505 | ||
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 1.70e-05 | 2 | 144 | 2 | 20408451 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26108359 | ||
| Pubmed | Tyrosine sulfation is a trans-Golgi-specific protein modification. | 1.70e-05 | 2 | 144 | 2 | 3121635 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 8041722 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21039965 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12560094 | ||
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 1.70e-05 | 2 | 144 | 2 | 26416749 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22745813 | ||
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 1.70e-05 | 2 | 144 | 2 | 28855340 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 1406633 | ||
| Pubmed | Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation. | 1.70e-05 | 2 | 144 | 2 | 26212909 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28220845 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 10806390 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 27678455 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 36006697 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16859706 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 37378433 | ||
| Pubmed | hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis. | 1.70e-05 | 2 | 144 | 2 | 36382566 | |
| Pubmed | Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1. | 1.70e-05 | 2 | 144 | 2 | 28821720 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 9733778 | ||
| Pubmed | Th1-like Plasmodium-Specific Memory CD4+ T Cells Support Humoral Immunity. | 1.70e-05 | 2 | 144 | 2 | 29141217 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 18243191 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 34374341 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31169879 | ||
| Pubmed | Identification of target genes for the CDK subunits of the Mediator complex. | 1.70e-05 | 2 | 144 | 2 | 22117896 | |
| Pubmed | 4.23e-05 | 223 | 144 | 7 | 20020773 | ||
| Pubmed | 4.28e-05 | 305 | 144 | 8 | 33194618 | ||
| Pubmed | 4.48e-05 | 225 | 144 | 7 | 12168954 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 4.95e-05 | 156 | 144 | 6 | 30409884 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 21454539 | ||
| Pubmed | PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1. | 5.09e-05 | 3 | 144 | 2 | 28115626 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 26002960 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 25917213 | ||
| Pubmed | Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells. | 5.09e-05 | 3 | 144 | 2 | 37903859 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 38320300 | ||
| Pubmed | Coronin 1B supports RhoA signaling at cell-cell junctions through Myosin II. | 5.09e-05 | 3 | 144 | 2 | 27650961 | |
| Pubmed | RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling. | 5.09e-05 | 3 | 144 | 2 | 25893381 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20685736 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 33692334 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17139268 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28526717 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28178657 | ||
| Pubmed | LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. | 5.09e-05 | 3 | 144 | 2 | 27166870 | |
| Pubmed | The Splicing Factor hnRNPA1 Regulates Alternate Splicing of the MYLK Gene. | 5.09e-05 | 3 | 144 | 2 | 29077485 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15972814 | ||
| Pubmed | A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1. | 5.09e-05 | 3 | 144 | 2 | 27151978 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28088441 | ||
| Pubmed | eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress. | 5.09e-05 | 3 | 144 | 2 | 20338999 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28039467 | ||
| Pubmed | Quaking regulates Hnrnpa1 expression through its 3' UTR in oligodendrocyte precursor cells. | 5.09e-05 | 3 | 144 | 2 | 21253564 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 33115498 | ||
| Pubmed | T-bet-dependent expression of osteopontin contributes to T cell polarization. | 5.09e-05 | 3 | 144 | 2 | 16286640 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15177565 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 10497246 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 19812035 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28151579 | ||
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 5.09e-05 | 3 | 144 | 2 | 23827524 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 25901972 | ||
| Pubmed | An interstitial telomere array proximal to the distal telomere of mouse chromosome 13. | 5.09e-05 | 3 | 144 | 2 | 9166585 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15774463 | ||
| Pubmed | Cell-autonomous role for NF-kappa B in immature bone marrow B cells. | 5.09e-05 | 3 | 144 | 2 | 19265118 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 37525910 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36823376 | ||
| Pubmed | Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis. | 5.09e-05 | 3 | 144 | 2 | 12128215 | |
| Pubmed | miR-146a controls the resolution of T cell responses in mice. | 5.09e-05 | 3 | 144 | 2 | 22891274 | |
| Pubmed | HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes. | 5.09e-05 | 3 | 144 | 2 | 24152440 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15390079 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17978477 | ||
| Pubmed | IFNγ inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms. | 5.09e-05 | 3 | 144 | 2 | 24369297 | |
| Interaction | OR9Q2 interactions | 1.11e-08 | 5 | 140 | 4 | int:OR9Q2 | |
| Cytoband | 3q27-q28 | 5.84e-05 | 4 | 144 | 2 | 3q27-q28 | |
| Cytoband | 19q13.2 | 1.76e-04 | 164 | 144 | 5 | 19q13.2 | |
| GeneFamily | Sulfotransferases, membrane bound | 5.26e-05 | 37 | 101 | 4 | 763 | |
| GeneFamily | Cyclin dependent kinases | 4.01e-04 | 26 | 101 | 3 | 496 | |
| GeneFamily | Arachidonate lipoxygenases | 4.57e-04 | 6 | 101 | 2 | 407 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.65e-04 | 115 | 101 | 5 | 769 | |
| GeneFamily | RNA binding motif containing | 1.25e-03 | 213 | 101 | 6 | 725 | |
| GeneFamily | Myosin heavy chains | 3.09e-03 | 15 | 101 | 2 | 1098 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.10e-06 | 192 | 144 | 7 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-06 | 200 | 144 | 7 | 3c9a2f02294a9fb892b89e856291bd6423ffa0a9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-06 | 200 | 144 | 7 | 8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.81e-06 | 145 | 144 | 6 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-05 | 152 | 144 | 6 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-05 | 154 | 144 | 6 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 177 | 144 | 6 | 1381aeb48a4133af060a9e2e7ce08b8b058e12c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 185 | 144 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-05 | 185 | 144 | 6 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.30e-05 | 187 | 144 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.30e-05 | 187 | 144 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.40e-05 | 188 | 144 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 190 | 144 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 190 | 144 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 3.82e-05 | 192 | 144 | 6 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.82e-05 | 192 | 144 | 6 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-05 | 192 | 144 | 6 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-05 | 192 | 144 | 6 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 3.93e-05 | 193 | 144 | 6 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.05e-05 | 194 | 144 | 6 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.41e-05 | 197 | 144 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 144 | 6 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 144 | 6 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Macroglial-Astrocyte|1m / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 144 | 6 | 4a6efb1b756995d217aacc38639c1bd40f1fd725 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 144 | 6 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.79e-05 | 200 | 144 | 6 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 144 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 1.85e-06 | 6 | 135 | 3 | DOID:0110306 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.72e-06 | 48 | 135 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 1.10e-05 | 10 | 135 | 3 | EFO_1000650, HP_0000131 | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 2.08e-05 | 2 | 135 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | uterine fibroid | 3.82e-05 | 199 | 135 | 7 | EFO_0000731 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 7.27e-05 | 18 | 135 | 3 | EFO_1000649, HP_0000131 | |
| Disease | tropical spastic paraparesis (is_implicated_in) | 1.24e-04 | 4 | 135 | 2 | DOID:321 (is_implicated_in) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 4.62e-04 | 33 | 135 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.55e-04 | 145 | 135 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | primary pulmonary hypertension (is_marker_for) | 5.71e-04 | 8 | 135 | 2 | DOID:14557 (is_marker_for) | |
| Disease | Glioma | 6.95e-04 | 87 | 135 | 4 | C0017638 | |
| Disease | lifestyle measurement, systolic blood pressure | 7.32e-04 | 9 | 135 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | thyroid carcinoma | 7.59e-04 | 39 | 135 | 3 | EFO_0002892 | |
| Disease | mitochondrial DNA measurement | 8.09e-04 | 328 | 135 | 7 | EFO_0006312 | |
| Disease | Uterine leiomyoma | 8.23e-04 | 91 | 135 | 4 | HP_0000131 | |
| Disease | venous thromboembolism, response to antineoplastic agent | 8.79e-04 | 41 | 135 | 3 | EFO_0004286, GO_0097327 | |
| Disease | serum gamma-glutamyl transferase measurement | WSCD1 ASAP3 NTNG1 ITGA1 HNRNPA1L3 THADA CAMKK2 SLC24A4 PTCD1 SIGLEC1 UBASH3B CDK6 | 1.03e-03 | 914 | 135 | 12 | EFO_0004532 |
| Disease | total blood protein measurement | 1.11e-03 | 449 | 135 | 8 | EFO_0004536 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.33e-03 | 12 | 135 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | neutrophil measurement | 1.36e-03 | 177 | 135 | 5 | EFO_0803548 | |
| Disease | male infertility (implicated_via_orthology) | 1.57e-03 | 13 | 135 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Hernia | 1.66e-03 | 51 | 135 | 3 | HP_0100790 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 1.82e-03 | 14 | 135 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | silicosis (biomarker_via_orthology) | 1.82e-03 | 14 | 135 | 2 | DOID:10325 (biomarker_via_orthology) | |
| Disease | eosinophil percentage of leukocytes | KIFBP PATZ1 RHBDD2 TERT HNRNPA1 THADA PPP5C NFKB1 CARD11 CDK6 | 2.33e-03 | 746 | 135 | 10 | EFO_0007991 |
| Disease | red blood cell density measurement | POGLUT3 TNRC6B ITGA1 RFX7 TERT FOCAD ZNF462 UBASH3B MYO15A RPL13A CDK6 | 2.44e-03 | 880 | 135 | 11 | EFO_0007978 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 2.53e-03 | 59 | 135 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 2.65e-03 | 60 | 135 | 3 | EFO_0020690 | |
| Disease | Psychoses, Substance-Induced | 2.70e-03 | 17 | 135 | 2 | C0033941 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.70e-03 | 17 | 135 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | sweet liking measurement | 3.03e-03 | 18 | 135 | 2 | EFO_0010156 | |
| Disease | comparative body size at age 10, self-reported | 3.28e-03 | 420 | 135 | 7 | EFO_0009819 | |
| Disease | lymphocyte percentage of leukocytes | 3.60e-03 | 665 | 135 | 9 | EFO_0007993 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.88e-03 | 139 | 135 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | MYH9 RASGRF2 KIF16B MSI1 RRAD TERT CIC KCNT2 KCNJ1 EIF4A2 GALNT5 GEN1 | 3.90e-03 | 1074 | 135 | 12 | C0006142 |
| Disease | mitochondrial heteroplasmy measurement | 3.94e-03 | 69 | 135 | 3 | EFO_0600008 | |
| Disease | Malignant Glioma | 4.10e-03 | 70 | 135 | 3 | C0555198 | |
| Disease | mixed gliomas | 4.10e-03 | 70 | 135 | 3 | C0259783 | |
| Disease | Psychoses, Drug | 4.12e-03 | 21 | 135 | 2 | C0033937 | |
| Disease | Manic Disorder | 4.27e-03 | 71 | 135 | 3 | C0024713 | |
| Disease | serum IgM measurement | 4.52e-03 | 22 | 135 | 2 | EFO_0004993 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRLFPNAKFLLMVRD | 171 | O60507 | |
| PRFFSMAEKRNSRAK | 1006 | Q7Z4L5 | |
| GMRPAANVARKFASI | 366 | P08173 | |
| PLFMRDFKRALGRFL | 321 | P50406 | |
| AFAAKMPRYRGAALA | 26 | Q8TDY4 | |
| MRKLFSFGRRLGQAL | 1 | Q8IVF6 | |
| RGRVKIADMGFARLF | 166 | Q9BWU1 | |
| TMFRDFGRRLQRDLK | 326 | Q9P1U1 | |
| MAGQAFRKFLPLFDR | 1 | P61604 | |
| ARPMRAIFLADGKVF | 221 | Q9BR76 | |
| NCLKTAGNPRDMRRF | 196 | Q9HAK2 | |
| MAAGRLFLSRLRAPF | 1 | Q16854 | |
| MFSGRFSRLPRIKTR | 1736 | Q6RI45 | |
| LGRRAKDPAVLRYMF | 86 | Q8IU99 | |
| GCIFAEMFRRKPLFR | 206 | Q00534 | |
| EMFRRKPLFRGSSDV | 211 | Q00534 | |
| RRIPILFFANKMDLR | 121 | Q9H0F7 | |
| KCRKRRMPVGRFQTF | 331 | Q9P209 | |
| LRGFRKPATGQMKRN | 231 | Q8IXJ9 | |
| MRKLFSFGRRLGQAL | 1 | Q9H560 | |
| ILLGRTNMFRFNHPK | 541 | Q96L93 | |
| TNKFGPRTRLRMASR | 331 | Q8NFF2 | |
| MRDPNTKRSRGFGFV | 46 | Q32P51 | |
| MRDPNTKRSRGFGFV | 1 | A0A2R8Y4L2 | |
| SGNKLFRRFRKMNAR | 966 | P15918 | |
| AAAMARRKLIPGTFQ | 196 | Q8TBY0 | |
| RAPPKARMALSFSRF | 571 | O75916 | |
| LAMAARKASRVRVPF | 191 | Q9NRN5 | |
| KYRRMSGVRPQSFRD | 196 | Q8IVL6 | |
| FLGRIVARNSRKMAF | 281 | P55042 | |
| KGTSRLFMGFRDRTP | 31 | Q9UKN7 | |
| LFMRFVSGRSRLPAN | 4771 | Q15751 | |
| FSELPQVRAMGKFFR | 256 | Q9Y2U2 | |
| ALFSRRQLFLPSMRK | 36 | P47224 | |
| PSMLRKNQLGFLRFA | 26 | Q8NA75 | |
| SSMVALKRLPFLRNR | 1461 | Q3V6T2 | |
| RPRRGMFRTVGQLYK | 661 | Q7Z406 | |
| LFSMERNRPLFKRLF | 446 | Q6ZWH5 | |
| FILMGLFRRSKHPAL | 16 | Q6IEZ7 | |
| GKPRRGMLRRAVFSD | 176 | A6NMT0 | |
| GLRRAAQKHSFPRML | 121 | Q8TEB1 | |
| FFRGHATMNTKRREP | 641 | Q8TET4 | |
| GQKFFIAGFRRSMRL | 371 | Q96JB8 | |
| ALPGAFKTRKGMFRT | 631 | P35579 | |
| KERERGSNLAFMFRL | 866 | Q6UVM3 | |
| LQNAHAMRRAFRGPK | 241 | Q9P215 | |
| AMRRAFRGPKNGRFA | 246 | Q9P215 | |
| PFLRRGEMVTFKILF | 891 | P56199 | |
| VMRDPLTKRSRGFGF | 51 | O43347 | |
| FLRKAEDFGNRLMPA | 351 | Q9UKM7 | |
| MLVNRFLGPKNSRRA | 551 | O95140 | |
| GRGRPRKANLLDSMF | 266 | Q9HBE1 | |
| NSSKFHFRRTRMLPV | 251 | Q8IVS2 | |
| SMRRGELARFLFKPN | 101 | O75344 | |
| LFRRILRSPMKFFDT | 951 | O15440 | |
| FFNIAKDPRVSMRRR | 81 | O94856 | |
| RFAPYLGQMRNLRKL | 221 | O95522 | |
| MKLPARVFFTLGSRL | 1 | Q16698 | |
| DLGKSYRMLRSFRPL | 721 | Q9UP83 | |
| MSPIGEVFRARLRQF | 2716 | Q9P2D7 | |
| LFRPRHTLDGAKMRA | 476 | Q08462 | |
| TMFRDFGRRLQRDLK | 326 | P61158 | |
| MSPIGDAFRNRLRMF | 2566 | Q8TD57 | |
| MNRIRKFFRGSGRVL | 1 | Q7Z7M9 | |
| RSFMGFAAPFTNKRK | 71 | Q96MF6 | |
| GRVFDMLNRRYLSPK | 161 | Q14240 | |
| FVRLGPMALAFKVRG | 211 | O75342 | |
| KDASLRRMSSNRFPG | 26 | Q8TDB4 | |
| FSRKLMARIFNGRPA | 441 | P48740 | |
| PRRGKMRFRRNAASF | 6 | P10911 | |
| APAFLNMRKRKRVTF | 381 | Q69YH5 | |
| SALLPKRAMQFGSRI | 596 | Q9NWL6 | |
| GSVMKPHLRNLFFRI | 46 | Q17RS7 | |
| LVKTMIRKRSFGNPF | 486 | Q96RR4 | |
| RQGRLYRQPKFLRTM | 231 | Q8IYD2 | |
| QPFGRGAMRECFRTK | 136 | O00418 | |
| GLFFSLMASRARKER | 306 | Q6IAN0 | |
| FLRAPRRKFMTVSGL | 56 | Q6UXB2 | |
| TLGKRRRAAMDFPGA | 291 | P48728 | |
| RGRVKIADMGFARLF | 166 | P49336 | |
| KLARRRNYMPLAFSD | 166 | Q9UJW0 | |
| MPFQSGEFKALTRRL | 146 | O00411 | |
| LVLRPRGFFMKTCFR | 856 | Q6ZTR5 | |
| VNLMFRKFSLERPFR | 636 | Q9BXL7 | |
| RPAMLAKFRVARLYG | 541 | Q96EK5 | |
| MRFISRNVFKRTLPG | 1846 | A6NMZ7 | |
| GKPLNRLMASRGRSF | 851 | Q5VW36 | |
| KNAFRRMGQPKRLNF | 1391 | Q13029 | |
| NPFIYTLRNRDMKRG | 286 | Q15619 | |
| GSAQRRKMRPFEGFQ | 511 | Q9BUJ2 | |
| MKTRGFSFPRQRQVL | 1 | Q9Y5E1 | |
| NEMKRIFNFRRTPAA | 211 | O15296 | |
| KDRFAFFAGPRLRNM | 226 | Q9Y2I2 | |
| SLKGVDPKFLRNMRF | 31 | P47914 | |
| RAKGESRIRRPMNAF | 61 | Q9H6I2 | |
| PGIFLLGQRKRFSTM | 46 | Q32P41 | |
| KTNRMTGREFFSRFP | 1276 | Q6YHU6 | |
| ITKQGRRMFPFLSFN | 226 | Q16650 | |
| PDSMGAFNRRKRNSI | 16 | Q5JRV8 | |
| SIFSLFRAPKLRMRV | 336 | Q8N4F4 | |
| FRAPKLRMRVFGLCF | 341 | Q8N4F4 | |
| VNGFLRPLRMAASSK | 266 | O14827 | |
| PVRMEAAKARFQAGR | 236 | Q96FV2 | |
| RRAASNMALGKFRAA | 101 | P53041 | |
| MFRAAAPGQLRRAAS | 1 | P13804 | |
| PIFEFSRAMRRLGLD | 351 | P55055 | |
| IMLLEAALPRFFRGA | 261 | Q7LGA3 | |
| ASIDMFPRQLRKSGR | 406 | P48065 | |
| LGFKAILPSFMRNKR | 61 | Q99909 | |
| QLKRPFGAFRSIMET | 856 | Q9Y6H5 | |
| MGNLLSKFRPGCRRR | 1 | Q9NZP6 | |
| FFQGGIPRALRRTLM | 271 | Q96DW6 | |
| EALRKLRMAGRSPSF | 301 | P0CW24 | |
| KATRFLPMDPATFRR | 586 | Q96RK0 | |
| RGPLQKAREMYRFAG | 376 | Q7LGC8 | |
| PAMRLFGYKLARDAA | 446 | Q7LGC8 | |
| NRFLMRKRLLFPALV | 356 | P51788 | |
| KPLDRNDGTFLMRYR | 91 | Q7Z4H8 | |
| PGNAMVRGFRVAYKR | 371 | Q9H4L4 | |
| RLFPNSKFLLMVRDG | 171 | O60704 | |
| LRSSFGKQYMLRRPA | 201 | Q9BVS5 | |
| LFGKPMVVQFARSAR | 491 | Q96LT9 | |
| AFLRKRMNTNPSRGP | 56 | P40429 | |
| ALKLDQTFPFSLMRR | 211 | Q6NTF9 | |
| KRRFQLGRSMNPRAR | 311 | A0A494C086 | |
| KRRFQLGRSMNPRAR | 311 | A6NIY4 | |
| GRFKIDLGIFRRAAM | 651 | Q9NXL6 | |
| KMPRLSFPRFGARAK | 356 | Q9BXM0 | |
| FRGPMAAISFPRKRL | 186 | Q969T3 | |
| FPNMKARRLGTRGKS | 61 | Q2KHR2 | |
| VMRDPQTKRSRGFGF | 66 | P51991 | |
| PKLVEARFRGRTEFM | 76 | Q9BZZ2 | |
| LLRQMGIRRIFSPFA | 351 | Q9UK55 | |
| NRVRMFGPDKLVRAA | 106 | P18887 | |
| ETKGIPFRRFMNRFQ | 426 | Q96JM2 | |
| SMGFPRARAQKALAS | 46 | Q8TF42 | |
| MAKPFFRLQKFLRRT | 1 | Q658N2 | |
| LARLFARARPMGLFI | 6 | O75127 | |
| MRDPNTKRSRGFGFV | 46 | P09651 | |
| VSGGAARLRFFSMKR | 1086 | Q6BDS2 | |
| NRGFKAGRNMRRKLF | 961 | O14746 | |
| KQGRRMFPFLSFTVA | 161 | Q9UL17 | |
| MREKGRRQAVRGPAF | 1 | Q13507 | |
| DFNDIMRKDRSGFRP | 1106 | Q9UPQ9 | |
| LFRLGKALMGLQRFR | 376 | Q49AM3 | |
| KLGRTLRSPFMKFVA | 376 | Q9HCX4 | |
| RARMKRGYDNPNFIL | 366 | P48048 | |
| EFFAPQRAGMKLRTF | 406 | A6PVS8 | |
| RKRQKLMPNFSDSFG | 361 | P19838 |